Edwin M Kania Jr insider trades: TransMedics Group (TMDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Edwin reports to the SEC
and 16 more companies
Open-market buys and sales
45 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | TMDX | ↑ Buy | 100,000 | $22.56 | $2.3M | Direct | Nov 30, 2021 (1d) |
| Jan 14, 2020 | MRNA | ↓ Sell | 475,000 | $20.26 | $9.6M | Direct | Jan 14, 2020 (0d) |
| Dec 11, 2019 | MRNA | ↓ Sell | 435,855 | $18.81 | $8.2M | Indirect | Dec 11, 2019 (0d) |
| Dec 10, 2019 | MRNA | ↓ Sell | 100,000 | $18.81 | $1.9M | Direct | Dec 11, 2019 (1d) |
| May 13, 2019 | AXLA | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | May 15, 2019 (2d) |
| May 6, 2019 | TMDX | ↑ Buy | 33,333 | $16.00 | $533K | Direct | May 6, 2019 (0d) |
| May 11, 2018 | EVLO | ↑ Buy | 281,250 | $16.00 | $4.5M | Indirect | May 15, 2018 (4d) |
| May 16, 2017 | SELB | ↓ Sell | 266,795 | $14.00 | $3.7M | Indirect | May 16, 2017 (0d) |
| Sep 23, 2016 | EBIO | ↓ Sell | 443,422 | $3.16 | $1.4M | Direct | Sep 26, 2016 (3d) |
| Sep 21, 2016 | EBIO | ↓ Sell | 386,340 | $3.69 | $1.4M | Direct | Sep 21, 2016 (0d) |
| Sep 15, 2016 | EBIO | ↓ Sell | 46,692 | $4.18 | $195K | Direct | Sep 16, 2016 (1d) |
| Sep 7, 2016 | EBIO | ↓ Sell | 129,497 | $4.54 | $588K | Direct | Sep 8, 2016 (1d) |
| Jul 6, 2016 | SYRS | ↑ Buy | 400,000 | $12.50 | $5.0M | Indirect | Jul 7, 2016 (1d) |
| May 25, 2016 | MCRB | ↓ Sell | 1,000,000 | $27.60 | $27.6M | Indirect | May 27, 2016 (2d) |
| Dec 23, 2014 | XLRN | ↓ Sell | 54,350 | $38.00 | $2.1M | Indirect | Dec 29, 2014 (6d) |
| Dec 11, 2014 | BGMD | ↓ Sell | 604,149 | $0.32 | $191K | Held by OneLiberty Fund IV, L.P. | Dec 11, 2014 (0d) |
| Dec 11, 2014 | BGMD | ↓ Sell | 30,241 | $0.32 | $10K | Held by OneLiberty Advisors Fund IV, L.P | Dec 11, 2014 (0d) |
| Dec 3, 2014 | BGMD | ↓ Sell | 2,463 | $0.46 | $1K | Held by NewcoGen Equity Investors LLC | Dec 5, 2014 (2d) |
| Dec 3, 2014 | BGMD | ↓ Sell | 1,848 | $0.46 | $850 | Held by NewcoGen Group LLC | Dec 5, 2014 (2d) |
| Dec 3, 2014 | BGMD | ↓ Sell | 260 | $0.46 | $120 | Held by NewcoGen-Long Reign Holding LLC | Dec 5, 2014 (2d) |
| Dec 3, 2014 | BGMD | ↓ Sell | 257 | $0.46 | $118 | Held by ST NewcoGen LLC | Dec 5, 2014 (2d) |
| May 5, 2014 | XLRN | ↓ Sell | 215,142 | $42.86 | $9.2M | Indirect | May 6, 2014 (1d) |
| Apr 24, 2014 | XLRN | ↓ Sell10b5-1 | 1,000,000 | $32.05 | $32.0M | Indirect | Apr 24, 2014 (0d) |
| Feb 11, 2014 | EBIO | ↑ Buy | 378,729 | $10.00 | $3.8M | Direct | Feb 13, 2014 (2d) |
| Nov 18, 2013 | RCPT | ↓ Sell | 230,787 | $24.75 | $5.7M | Direct | Nov 18, 2013 (0d) |
| Sep 25, 2013 | BIND | ↑ Buy | 20,000 | $15.00 | $300K | Indirect | Sep 27, 2013 (2d) |
| May 14, 2013 | RCPT | ↑ Buy | 107,142 | $14.00 | $1.5M | Direct | May 14, 2013 (0d) |
| Mar 25, 2013 | TTPH | ↑ Buy | 491,824 | $7.00 | $3.4M | Direct | Mar 27, 2013 (2d) |
| Jan 30, 2013 | BGMD | ↑ Buy | 1,050,000 | $2.00 | $2.1M | By Flagship Ventures Fund 2007, L.P. | Feb 1, 2013 (2d) |
| Jan 30, 2013 | BGMD | ↑ Buy | 500,000 | $2.00 | $1.0M | By Applied Genomic Technology Capital Fu | Feb 1, 2013 (2d) |
| Jan 30, 2013 | BGMD | ↑ Buy | 250,000 | $2.00 | $500K | By NewcoGen Group LLC | Feb 1, 2013 (2d) |
| Jan 30, 2013 | BGMD | ↑ Buy | 125,000 | $2.00 | $250K | By NewcoGen Equity Investors LLC | Feb 1, 2013 (2d) |
| Jan 30, 2013 | BGMD | ↑ Buy | 75,000 | $2.00 | $150K | By AGTC Advisors Fund, L.P. | Feb 1, 2013 (2d) |
| Aug 20, 2012 | BGMD | ↓ Sell | 82 | $5.83 | $478 | By NewcoGen-Elan LLC | Aug 22, 2012 (2d) |
| May 21, 2012 | BGMD | ↓ Sell | 141 | $3.95 | $557 | By NewcoGen-PE LLC | May 23, 2012 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 714,286 | $7.00 | $5.0M | By Flagship Ventures Fund 2007, L.P. | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 271,429 | $7.00 | $1.9M | By Applied Genomic Technology Capital Fu | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 42,858 | $7.00 | $300K | By NewcoGen Group LLC | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 35,715 | $7.00 | $250K | By NewcoGen Equity Investors LLC | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 21,428 | $7.00 | $150K | By NewcoGen-Long Reign Holding LLC | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 21,428 | $7.00 | $150K | By ST NewcoGen LLC | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 14,285 | $7.00 | $100K | By AGTC Advisors Fund, L.P. | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 10,714 | $7.00 | $75K | By NewcoGen-Elan LLC | Feb 11, 2011 (2d) |
| Feb 9, 2011 | BGMD | ↑ Buy | 10,714 | $7.00 | $75K | By NewcoGen-PE LLC | Feb 11, 2011 (2d) |
| May 30, 2007 | HLCS | ↑ Buy | 222,222 | $9.00 | $2.0M | Indirect | May 31, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TMDX insiders
Open-market trades in the last 12 months
About Edwin M Kania Jr's insider trades
Edwin M Kania Jr is an insider at TransMedics Group (TMDX). Since May 30, 2007, Edwin has reported 24 open-market purchases worth $45.3M and 21 sales worth $103.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (31% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include other transactions (23 filings), conversions (22 filings), grants and awards (19 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TMDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.